Japanese SearchCareersSitemapContact

Dr Terunuma Hiroshi (Sitting-Right) with his team of scientists and Research officers at their Biotherapy Institute, Tokyo , Japan
The need of the hour when we were approached by a physician whose young and only daughter became a victim to blood cancer called Acute Myeloid Leukemia (AML) with no matching donor for Bone Marrow Transfusion (BMT) and unavailability of Umbilical Cord Blood either matched (6/6) or even mismatched (4/6), was the state-of-the-art technology, laboratory reagents, training etc., NCRM being an Indo-Japan joint venture institute and with several collaborations with Japanese institutes, we had earlier initiated discussions to start the Immunotherapy for Cancer patients in India, but the original plan was to start the same in October.

Upon hearing the SOS message from a patient, on war foot, we started organizing things to start the same to save a child with AML. Dr Terunuma Hiroshi, formerly was with the Tokyo Medical and Dental University Hospital working on Cell Biology and Immunology was our collaborator in this venture and he immediately started helping us with every thing we needed to start the Autologous Immune Enhancement Therapy in India. To formalize this collaboration, a formal MoU was signed among M/S Nichi-In Centre for Regenerative Medicine, India and M/S Biotherapy Institute, Japan.

The Biotherapy Institute is having three state-of-the-art clinical cell processing units as per cGMP standards in Tokyo with more than 50 scientists and research officers working there. They have clinical affiliation with several hospitals in and around Tokyo city for offering the Immunotherapy. They have crossed more than 1000 cases of Immunotherapy till date with very good results.

Dr. Terunuma Hiroshi, the scientific head of the institute has more than 100 publications in this specialty to his credit and also a couple of patents.

 Press release Media coverage about the collaboration: The Hindu News Today
*"Nichi" stands for Japan and "In" stands for India. This institute started on an Indo-Japan collaboration now has spreaded further with global alliances
    © NCRM. All right reserved.                                                                                                                                                                                          Disclaimer